ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,365Medicare Part D Prescriptions Filled, Including Refills
$355K Total Retail Price of All Prescriptions
316 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
SIMVASTATIN 327 326
LISINOPRIL 278 265
LEVOTHYROXINE SODIUM 274 269
OMEPRAZOLE 257 248
AMLODIPINE BESYLATE 227 218
FUROSEMIDE 205 205
ATENOLOL 200 195
METOPROLOL SUCCINATE 199 199
WARFARIN SODIUM 190 177
TAMSULOSIN HCL 172 167
LOSARTAN POTASSIUM 171 171
HYDROCHLOROTHIAZIDE 160 157
LOVASTATIN 145 141
ALLOPURINOL 145 145
LISINOPRIL-HYDROCHLOROTHIAZIDE 132 132
ALENDRONATE SODIUM 118 105
PRAVASTATIN SODIUM 91 88
FINASTERIDE 90 90
HYDROCODONE-ACETAMINOPHEN 90 86 S3
METFORMIN HCL 87 87
POTASSIUM CHLORIDE 86 86
CARVEDILOL 84 84
DOXAZOSIN MESYLATE 78 74
TRAMADOL HCL 78 65
PREDNISONE 74 72
MIRTAZAPINE 72 72
METOPROLOL TARTRATE 65 65
CRESTOR 62 57
LANTUS 61 48
FLUOXETINE HCL 58 58
FLUTICASONE PROPIONATE 57 53
LOSARTAN-HYDROCHLOROTHIAZIDE 57 57
SPIRONOLACTONE 56 51
NEXIUM 56 32
BENAZEPRIL HCL 55 47
METFORMIN HCL ER 55 52
CITALOPRAM HBR 53 48
NADOLOL 52 52
POLYETHYLENE GLYCOL 3350 52 52
ATORVASTATIN CALCIUM 51 51
TRIAMTERENE-HCTZ 51 51
AZITHROMYCIN 50 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.